<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; on</title>
	<atom:link href="http://www.tapanray.in/tag/on/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>‘The Pharmacy of the Developing World’ keeps its eye on the ball to emerge as ‘The Pharmacy of the World’</title>
		<link>http://www.tapanray.in/the-pharmacy-of-the-developing-world-keeps-its-eye-on-the-ball-to-emerge-as-the-pharmacy-of-the-world/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-pharmacy-of-the-developing-world-keeps-its-eye-on-the-ball-to-emerge-as-the-pharmacy-of-the-world</link>
		<comments>http://www.tapanray.in/the-pharmacy-of-the-developing-world-keeps-its-eye-on-the-ball-to-emerge-as-the-pharmacy-of-the-world/#comments</comments>
		<pubDate>Sun, 28 Oct 2012 00:00:25 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[abbott]]></category>
		<category><![CDATA[as]]></category>
		<category><![CDATA[ball]]></category>
		<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Clinical]]></category>
		<category><![CDATA[Compulsory Licensing]]></category>
		<category><![CDATA[Counterfeit]]></category>
		<category><![CDATA[Developing]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[emerge]]></category>
		<category><![CDATA[Ethical Marketing]]></category>
		<category><![CDATA[eye]]></category>
		<category><![CDATA[FDI]]></category>
		<category><![CDATA[glaxo]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[GSK]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Hospital]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[IPR]]></category>
		<category><![CDATA[its]]></category>
		<category><![CDATA[keeps]]></category>
		<category><![CDATA[kopran]]></category>
		<category><![CDATA[Legal]]></category>
		<category><![CDATA[Medical Diagnostics]]></category>
		<category><![CDATA[medicine]]></category>
		<category><![CDATA[Neutraceutical]]></category>
		<category><![CDATA[NPPA]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[on]]></category>
		<category><![CDATA[OPPI]]></category>
		<category><![CDATA[Patents]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Pharmacy]]></category>
		<category><![CDATA[PHC]]></category>
		<category><![CDATA[Policy]]></category>
		<category><![CDATA[Pricing]]></category>
		<category><![CDATA[RDP]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[Research & Development]]></category>
		<category><![CDATA[sami]]></category>
		<category><![CDATA[Spurious]]></category>
		<category><![CDATA[stakeholders]]></category>
		<category><![CDATA[strategy]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[therapeutic]]></category>
		<category><![CDATA[Trials]]></category>
		<category><![CDATA[World]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=1075</guid>
		<description><![CDATA[The incessant march of the home grown pharmaceutical companies of India in search of excellence, especially in the space of high quality low cost generic medicines for almost all disease areas, continues at a scorching space, probably more than ever &#8230; <a href="http://www.tapanray.in/the-pharmacy-of-the-developing-world-keeps-its-eye-on-the-ball-to-emerge-as-the-pharmacy-of-the-world/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-pharmacy-of-the-developing-world-keeps-its-eye-on-the-ball-to-emerge-as-the-pharmacy-of-the-world/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Finance Ministry Disallows Expenses on &#8216;Freebies&#8217; to Doctors by Pharma Companies in line with MCI Guidelines: A Possible Game Changer?</title>
		<link>http://www.tapanray.in/finance-ministry-disallows-expenses-on-freebies-to-doctors-by-pharma-companies-in-line-with-mci-guidelines-a-possible-game-changer/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=finance-ministry-disallows-expenses-on-freebies-to-doctors-by-pharma-companies-in-line-with-mci-guidelines-a-possible-game-changer</link>
		<comments>http://www.tapanray.in/finance-ministry-disallows-expenses-on-freebies-to-doctors-by-pharma-companies-in-line-with-mci-guidelines-a-possible-game-changer/#comments</comments>
		<pubDate>Mon, 06 Aug 2012 00:00:12 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[by]]></category>
		<category><![CDATA[Changer]]></category>
		<category><![CDATA[companies]]></category>
		<category><![CDATA[Disallows]]></category>
		<category><![CDATA[doctors]]></category>
		<category><![CDATA[Expenses]]></category>
		<category><![CDATA[Finance]]></category>
		<category><![CDATA[Freebies]]></category>
		<category><![CDATA[Game]]></category>
		<category><![CDATA[Guidelines]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[line]]></category>
		<category><![CDATA[MCI]]></category>
		<category><![CDATA[Ministry]]></category>
		<category><![CDATA[on]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Possible]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[with]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=56</guid>
		<description><![CDATA[Things are unfolding reasonably faster now related to the financial relationship between the pharmaceutical companies and the medical profession. All these issues are getting increasingly dragged into the public debate where government can no longer play the role of a &#8230; <a href="http://www.tapanray.in/finance-ministry-disallows-expenses-on-freebies-to-doctors-by-pharma-companies-in-line-with-mci-guidelines-a-possible-game-changer/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/finance-ministry-disallows-expenses-on-freebies-to-doctors-by-pharma-companies-in-line-with-mci-guidelines-a-possible-game-changer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Bollywood Matinee Idol Pontifies on Pharma FDI with Razzmatazz: Exploring Facts</title>
		<link>http://www.tapanray.in/bollywood-matinee-idol-pontifies-on-pharma-fdi-with-razzmatazz-exploring-facts/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=bollywood-matinee-idol-pontifies-on-pharma-fdi-with-razzmatazz-exploring-facts</link>
		<comments>http://www.tapanray.in/bollywood-matinee-idol-pontifies-on-pharma-fdi-with-razzmatazz-exploring-facts/#comments</comments>
		<pubDate>Mon, 09 Jul 2012 00:00:29 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Aamir]]></category>
		<category><![CDATA[Bollywood]]></category>
		<category><![CDATA[Exploring]]></category>
		<category><![CDATA[Facts]]></category>
		<category><![CDATA[FDI]]></category>
		<category><![CDATA[Idol]]></category>
		<category><![CDATA[Khan]]></category>
		<category><![CDATA[Matinee]]></category>
		<category><![CDATA[on]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Pontifies]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Razzmatazz]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[with]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=69</guid>
		<description><![CDATA[It has been widely reported  by the media that Bollywood matinee idol Aamir Khan was invited by the Parliamentary Standing Committee  (PSC) on commerce to express his views on Foreign Direct Investments (FDI) in the pharmaceutical sector of India on &#8230; <a href="http://www.tapanray.in/bollywood-matinee-idol-pontifies-on-pharma-fdi-with-razzmatazz-exploring-facts/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/bollywood-matinee-idol-pontifies-on-pharma-fdi-with-razzmatazz-exploring-facts/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Healthcare Tourism: India needs to step on the gas</title>
		<link>http://www.tapanray.in/healthcare-tourism-india-needs-to-step-on-the-gas/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=healthcare-tourism-india-needs-to-step-on-the-gas</link>
		<comments>http://www.tapanray.in/healthcare-tourism-india-needs-to-step-on-the-gas/#comments</comments>
		<pubDate>Mon, 30 Jan 2012 00:00:15 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[gas]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[needs]]></category>
		<category><![CDATA[on]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[step]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[Tourism]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=140</guid>
		<description><![CDATA[Healthcare Tourism or Medical Tourism are the terminologies initially coined by the travel agents and the media when patients travel outside their national boundaries to seek either more specialized and/or cheaper but high quality healthcare available in other countries. World &#8230; <a href="http://www.tapanray.in/healthcare-tourism-india-needs-to-step-on-the-gas/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/healthcare-tourism-india-needs-to-step-on-the-gas/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biologic Drugs: The hunt for the ‘Magic Bullets’ is on</title>
		<link>http://www.tapanray.in/biologic-drugs-the-hunt-for-the-magic-bullets-is-on/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=biologic-drugs-the-hunt-for-the-magic-bullets-is-on</link>
		<comments>http://www.tapanray.in/biologic-drugs-the-hunt-for-the-magic-bullets-is-on/#comments</comments>
		<pubDate>Mon, 05 Dec 2011 00:00:42 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[Biologic]]></category>
		<category><![CDATA[biosimilar]]></category>
		<category><![CDATA[bullets]]></category>
		<category><![CDATA[cliff]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[hunt]]></category>
		<category><![CDATA[is]]></category>
		<category><![CDATA[magic]]></category>
		<category><![CDATA[on]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=165</guid>
		<description><![CDATA[The global pharmaceutical industry is now navigating its way through very cautiously while negotiating an unprecedented ‘patent cliff’, simultaneously with gradually drying-up R&#38;D pipelines. This unique situation has triggered off several global mega Mergers and Acquisitions (M&#38;A) not only involving &#8230; <a href="http://www.tapanray.in/biologic-drugs-the-hunt-for-the-magic-bullets-is-on/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/biologic-drugs-the-hunt-for-the-magic-bullets-is-on/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Why does the Government divert focus on to fringe issues to address critical healthcare concerns of the nation?</title>
		<link>http://www.tapanray.in/why-does-the-government-divert-focus-on-to-fringe-issues-to-address-critical-healthcare-concerns-of-the-nation/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=why-does-the-government-divert-focus-on-to-fringe-issues-to-address-critical-healthcare-concerns-of-the-nation</link>
		<comments>http://www.tapanray.in/why-does-the-government-divert-focus-on-to-fringe-issues-to-address-critical-healthcare-concerns-of-the-nation/#comments</comments>
		<pubDate>Mon, 04 Oct 2010 01:00:42 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[address]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[CL]]></category>
		<category><![CDATA[Compulsory]]></category>
		<category><![CDATA[concerns]]></category>
		<category><![CDATA[critical]]></category>
		<category><![CDATA[delivery]]></category>
		<category><![CDATA[divert]]></category>
		<category><![CDATA[focus]]></category>
		<category><![CDATA[fringe]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[infrastructure]]></category>
		<category><![CDATA[IP]]></category>
		<category><![CDATA[IPR]]></category>
		<category><![CDATA[Issues]]></category>
		<category><![CDATA[License]]></category>
		<category><![CDATA[nation]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[on]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[spend]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[to]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=366</guid>
		<description><![CDATA[The Department of Industrial Policy and Promotion (DIPP) of the Ministry of Commerce and Industry of the Government of India has recently initiated a public debate through a ‘Discussion Paper on Compulsory Licensing (CL) of Patented Pharmaceutical Products’. The key &#8230; <a href="http://www.tapanray.in/why-does-the-government-divert-focus-on-to-fringe-issues-to-address-critical-healthcare-concerns-of-the-nation/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/why-does-the-government-divert-focus-on-to-fringe-issues-to-address-critical-healthcare-concerns-of-the-nation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hype on “Superbug” – national pride – rational mind</title>
		<link>http://www.tapanray.in/hype-on-superbug-national-pride-rational-mind/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=hype-on-superbug-national-pride-rational-mind</link>
		<comments>http://www.tapanray.in/hype-on-superbug-national-pride-rational-mind/#comments</comments>
		<pubDate>Mon, 23 Aug 2010 01:30:02 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[antibiotic]]></category>
		<category><![CDATA[chemists]]></category>
		<category><![CDATA[doctors]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[Hype]]></category>
		<category><![CDATA[Lancet]]></category>
		<category><![CDATA[mind]]></category>
		<category><![CDATA[Ministry]]></category>
		<category><![CDATA[misuse]]></category>
		<category><![CDATA[MoH]]></category>
		<category><![CDATA[MSRA]]></category>
		<category><![CDATA[National]]></category>
		<category><![CDATA[NewDelhi 1]]></category>
		<category><![CDATA[of health]]></category>
		<category><![CDATA[on]]></category>
		<category><![CDATA[Patients]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[pride]]></category>
		<category><![CDATA[rational]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Superbug]]></category>
		<category><![CDATA[Tapan]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=384</guid>
		<description><![CDATA[Since around last fortnight Indian media of all types and forms, have been fiercely competing with each other to attract the ‘eye balls’ of the viewer/readers through ‘alarming&#8217; news items starting from the situation in the J&#38;K to the &#8216;rampant &#8230; <a href="http://www.tapanray.in/hype-on-superbug-national-pride-rational-mind/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/hype-on-superbug-national-pride-rational-mind/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>My thoughts on the world IPR day, April 24</title>
		<link>http://www.tapanray.in/my-thoughts-on-the-world-ipr-day-april-24/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=my-thoughts-on-the-world-ipr-day-april-24</link>
		<comments>http://www.tapanray.in/my-thoughts-on-the-world-ipr-day-april-24/#comments</comments>
		<pubDate>Mon, 26 Apr 2010 00:00:49 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[April 24]]></category>
		<category><![CDATA[day]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[IPR]]></category>
		<category><![CDATA[My]]></category>
		<category><![CDATA[on]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[regime Act]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[thoughts]]></category>
		<category><![CDATA[World]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=436</guid>
		<description><![CDATA[Ushering in the Product Patent Regime in India, effective January 1, 2005, heralds the dawn of a new era… an era that is expected to add speed to the wheels of progress of the nation. The new paradigm vindicates the &#8230; <a href="http://www.tapanray.in/my-thoughts-on-the-world-ipr-day-april-24/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/my-thoughts-on-the-world-ipr-day-april-24/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The ‘Climate Change’ and its impact on ‘Public health’: is there anything in it that we can do ourselves?</title>
		<link>http://www.tapanray.in/the-climate-change-and-its-impact-on-public-health-is-there-anything-in-it-that-we-can-do-ourselves/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-climate-change-and-its-impact-on-public-health-is-there-anything-in-it-that-we-can-do-ourselves</link>
		<comments>http://www.tapanray.in/the-climate-change-and-its-impact-on-public-health-is-there-anything-in-it-that-we-can-do-ourselves/#comments</comments>
		<pubDate>Mon, 01 Mar 2010 02:00:41 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[anything]]></category>
		<category><![CDATA[can]]></category>
		<category><![CDATA[Change]]></category>
		<category><![CDATA[Climate]]></category>
		<category><![CDATA[do]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[IMPACT]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[it]]></category>
		<category><![CDATA[its]]></category>
		<category><![CDATA[on]]></category>
		<category><![CDATA[ourselves]]></category>
		<category><![CDATA[public]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[that]]></category>
		<category><![CDATA[there]]></category>
		<category><![CDATA[we]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=461</guid>
		<description><![CDATA[The Lancet in its December 5, 12 and 19, 2009 issues published the following interesting studies:A. Public health benefits of strategies to reduce greenhouse-gas emissions: household energy B. Public health benefits of strategies to reduce greenhouse-gas emissions: urban land transport &#8230; <a href="http://www.tapanray.in/the-climate-change-and-its-impact-on-public-health-is-there-anything-in-it-that-we-can-do-ourselves/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-climate-change-and-its-impact-on-public-health-is-there-anything-in-it-that-we-can-do-ourselves/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Does the Indian Patents Act conform to Article 27 (Patentable Subject Matter) of TRIPS on the issue of ‘local working of patents’?</title>
		<link>http://www.tapanray.in/does-the-indian-patents-act-conform-to-article-27-patentable-subject-matter-of-trips-on-the-issue-of-local-working-of-patents/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=does-the-indian-patents-act-conform-to-article-27-patentable-subject-matter-of-trips-on-the-issue-of-local-working-of-patents</link>
		<comments>http://www.tapanray.in/does-the-indian-patents-act-conform-to-article-27-patentable-subject-matter-of-trips-on-the-issue-of-local-working-of-patents/#comments</comments>
		<pubDate>Mon, 22 Feb 2010 01:00:47 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[27]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[Article]]></category>
		<category><![CDATA[conform]]></category>
		<category><![CDATA[Does]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[issue]]></category>
		<category><![CDATA[local]]></category>
		<category><![CDATA[Matter]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[on]]></category>
		<category><![CDATA[Patentable]]></category>
		<category><![CDATA[Patents]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Subject]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[TRIPS]]></category>
		<category><![CDATA[working]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=464</guid>
		<description><![CDATA[India is one of the signatories of TRIPS and has a national commitment on adherence to this important international agreement. It is, therefore, widely believed that the amended Indian Patents Act will be TRIPS compliant. A recent circular from CGPTD: &#8230; <a href="http://www.tapanray.in/does-the-indian-patents-act-conform-to-article-27-patentable-subject-matter-of-trips-on-the-issue-of-local-working-of-patents/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/does-the-indian-patents-act-conform-to-article-27-patentable-subject-matter-of-trips-on-the-issue-of-local-working-of-patents/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
